Failure to Implement INR Monitoring Orders for Resident on Warfarin
Summary
The deficiency involves the facility’s failure to ensure that INR testing was ordered and completed for a resident receiving warfarin therapy, as required by professional standards and the facility’s own anticoagulation policy. The resident was admitted with diagnoses including cognitive symptoms following a nontraumatic subarachnoid hemorrhage and the presence of a prosthetic heart valve, and had an active order for warfarin 5 mg by mouth in the evening. The resident’s care plan identified anticoagulant therapy with an intervention for labs and diagnostics as ordered, and the hospital discharge summary documented that the resident had a high INR upon hospital admission and required an INR check early the following week after admission to the facility, with weekly INR checks for several weeks. Review of the resident’s order summary showed no INR test orders in place, and the DON confirmed that no INR testing had been completed while the resident was at the facility. Interviews with facility staff revealed that the ADON was responsible for entering all admission orders, including lab orders, into the EMR and the lab ordering system, but the ADON no longer worked at the facility. The DON stated there was no process for anyone to verify that all admission orders were correctly entered after the ADON, and was unsure why all of the resident’s admission orders were not in the EMR. The unit manager reported not having seen the resident’s discharge paperwork but stated that, based on the instructions, he or she would have entered INR testing orders and contacted the physician to confirm. RN A stated that he or she was not responsible for entering admission orders. The attending physician reported expecting the facility to follow all discharge instructions, including placing INR orders into the EMR, and stated that the resident should have had weekly INR orders in place given the resident’s history and hospital course. The facility’s anticoagulation policy required identification of anticoagulated residents, review of recent labs and therapeutic monitoring, and close INR monitoring for residents on warfarin, but this process was not carried out for this resident.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.